CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 121 filers reported holding CARIBOU BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $9,457,000 | -21.0% | 896,369 | -59.3% | 0.05% | -20.0% |
Q2 2022 | $11,967,000 | -50.9% | 2,203,895 | -17.1% | 0.06% | -44.9% |
Q1 2022 | $24,392,000 | -45.5% | 2,657,052 | -10.3% | 0.12% | -47.1% |
Q4 2021 | $44,718,000 | -36.8% | 2,963,448 | 0.0% | 0.22% | -32.4% |
Q3 2021 | $70,738,000 | – | 2,963,448 | – | 0.33% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
72 Investment Holdings, LLC | 474,067 | $11,316,000 | 14.13% |
Memorial Sloan Kettering Cancer Center | 674,196 | $16,093,000 | 10.03% |
PFM Health Sciences, LP | 4,092,309 | $88,176,000 | 2.59% |
CloudAlpha Capital Management Limited/Hong Kong | 305,000 | $7,280,000 | 2.15% |
Monashee Investment Management LLC | 449,377 | $10,727,000 | 1.98% |
Avidity Partners Management LP | 2,474,067 | $59,056,000 | 1.31% |
Green Alpha Advisors, LLC | 32,836 | $784,000 | 0.54% |
Tekla Capital Management LLC | 699,377 | $15,621,000 | 0.50% |
SPHERA FUNDS MANAGEMENT LTD. | 200,000 | $4,774,000 | 0.40% |
FARALLON CAPITAL MANAGEMENT LLC | 2,963,448 | $70,738,000 | 0.33% |